The record

LegislationLegislation· Aug 2026
S 4472 Passed Senate — in House

Sponsored by Lisa Murkowski (R)

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

Extends funding for ALS research and therapy development programs through 2031.

Tradeoff

Reauthorizes federal grants and public-private partnerships for amyotrophic lateral sclerosis (ALS) research and drug development through 2031. Adds new reporting requirements on grant safety data and FDA progress on rare neurodegenerative disease treatments.

What's in it

See official bill text

Passed the Senate by on August 4, 2026 — now in the House.

  1. Senate

    Introduced

    (Apr 30, 2026)

  2. Senate

    Committee on Health, Education, Labor, and Pensions(Apr 30, 2026)

  3. Senate

    The Committee on Health, Education, Labor, and Pensions voted to send it to the floor

    Reported(Jun 17, 2026)

  4. Senate

    Passage of the bill

    Passed by (Aug 4, 2026)

    No individual votes were recorded.

  5. House

    Received from the Senate

    Received(Aug 10, 2026)